Scientific Sessions 2025  /  Hypertrophic Cardiomyopathy Across the Lifespan: Risk Stratification, Diagnosis, and Management  /  Future Directions in hypertrophic cardiomyopathy treatment and management
Logo

American Heart Association

  29
  0

Final ID:

Future Directions in hypertrophic cardiomyopathy treatment and management

  • Grosse-wortmann, Lars  ( OHSU , Portland , Oregon , United States )
  • Balaji, Seshadri  ( OHSU , Portland , Oregon , United States )
    • Author Disclosures:
    Lars Grosse-Wortmann: DO NOT have relevant financial relationships | Seshadri Balaji: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Hypertrophic Cardiomyopathy Across the Lifespan: Risk Stratification, Diagnosis, and Management

Saturday, 11/08/2025 , 03:15PM - 04:30PM

Cardiovascular Seminar

More abstracts on this topic:
Case presentation: SCD risk stratification in a 15-year-old with incidentally diagnosed HCM

Newlon Claire, Hayes Emily

Case presentation: 5 year old Noonan’s patient with HCM entering school

Kamsheh Alicia, Dham Niti

More abstracts from these authors:
When and Where to Pace the Fontan Circulation

Balaji Seshadri, Mah Douglas, Chubb Henry

Children’s Heartbeat: Improving Global Knowledge and Care of Pediatric Arrhythmias

Gakenheimer-smith Lindsey, Etheridge Susan, Batra Anjan, Sanatani Shubhayan, Holiman Hannah, Nahey Tara, Balaji Seshadri

You have to be authorized to contact abstract author. Please, Login
Not Available